Building the European Reference Network for Rare Endocrine Conditions (Endo-ERN) Journee Annuelle, FIRENDO, Paris, 14 december 2016

Similar documents
EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

Cross Border Genetic Testing for Rare Diseases

International Workshop of Sex Development and Maturation

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

The European Reference Network in Rare Hematological Diseases

Current dietary habits in Europe far from plant based eating

Overview of European Consumption Databases

NORDIC CONFERENCE ON RARE DISEASES

Overview of drug-induced deaths in Europe - What does the data tell us?

Where we stand in EFORT

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

Extrapolation and potential impact of IPHS deployment in Europe

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France)

WCPT COUNTRY PROFILE December 2017 SERBIA

Engagement in language assessment / Regions of Europe

Visegrád, Hungary, February 22-25, 2018

INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation

SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES. Domenica Taruscio

Monthly measles and rubella monitoring report

We are here for our fellow patients

Real Life, Real PD Survey

'SECTION B EU PARTY. The following abbreviations are used:

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Joint Programming in Neurodegenerative Disease Research (JPND)

CNAPA Meeting Luxembourg September 2016

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Measles and rubella monitoring January 2015

What s s on the Menu in Europe? - overview and challenges in the first pan- European food consumption survey

Smokefree Policies in Europe: Are we there yet?

European Dietetic Action Plan Progress report 2017

Transmission, processing and publication of HBS 2015 data

European Status report on Alcohol and Health

Towards Integrated Syndromic Surveillance in Europe?

Project Meeting Prague

European Collaboration on Dementia. Luxembourg, 13 December 2006

Table Of Content. European Surveillance of Congenital Anomalies (Phase 3)... 3 Summary... 4 Coordinator, Leader contact and partners...

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

Europa Donna in Europe and in Slovenia

The health economic landscape of cancer in Europe

EUROPLAN National Conferences and Post-NCs activities in support to Member States

The Identification of Food Safety Priorities using the Delphi Technique

EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL

Open Access & research metrics Establishing reliable baselines for science policy

UK bowel cancer care outcomes: A comparison with Europe

STRATEGIC APPROACH & WORKPLAN 2007

NATIONAL REGISTRIES OF RARE DISEASES IN EUROPE: AN OVERVIEW BY THE EPIRARE PROJECT.

European Community Pharmacy: a reference in Public Health

International Meeting of Pediatric Endocrinology Special Interest Group Descriptions Date: Thursday September 14 th, 2017 Time: 8:30 am 11:30 am

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

ImpARAS. Improving Allergy Risk Assessment Strategy for new food proteins. Kitty Verhoeckx, Scientist, TNO, The Netherlands

BBMRI-ERIC and BBMRI.fi

Meeting report, September 2005

Nutrient profiles for foods bearing claims

Screening for Cervical Cancer in Europe

Highlighting in the WHO European Region:

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

European Patients Academy on Therapeutic Innovation

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

A global network for EB specialists

Supporting carers through the web: the road towards a new European web platform

ICMART. International Council of Medical Acupuncture and Related Techniques

the patients perspective and role of epags

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

A European Union-wide slaughterhouse baseline survey on the prevalence of Salmonella in slaughter pigs

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH

ECOO European Diploma in Optometry and Optics ECOO European Diploma in Optics A Status Report

Curriculum Vitae Training in Systems Biology, Chalmers Technical University, Sweden Project title: Modelling Gut Microbiome in Obesity

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Meeting with EMA: cooperation in the field of ERNs. Enrique Terol DG SANTE European Commission

Amoxicillin 40 mg Clavulanic acid 10 mg. Clavulanic acid 10 mg. Clavulanic acid 10 mg. Clavulanic acid 10 mg

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Alzheimer Europe. European Collaboration on Dementia

Families across Europe following a healthy Lifestyle FOR Diabetes prevention : Feel4Diabetes

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Integrating the Healthcare Enterprise The IHE Initiative Worldwide IHE Europe Karima Bourquard IHE Europe user Cochair

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

European monthly measles monitoring (EMMO)

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Overall survival: 1 st line therapy

Outcome of proficiency test on EIA serology

EUVAC.NET A surveillance network for vaccine-preventable diseases

Table 6.1 Summary information for colorectal cancer in Ireland,

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Table Of Content. Outputs... 12

National Clinical Programme for Rare Diseases Prof. Eileen Treacy April 7 th,

CHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant

Transcription:

Building the European Reference Network for Rare Endocrine Conditions (Endo-ERN) Journee Annuelle, FIRENDO, Paris, 14 december 2016 Alberto M. Pereira

European Reference Networks: Scope and Context Article 12 Directive of patients' rights in cross-border healthcare Networks of healthcare providers aiming at: Improving quality and safety and access to highly specialised healthcare across the EU Patients affected by rare or low prevalence and complex diseases Added value ( EU level ) Need for Cooperation: Scarcity of knowledge Need for education Complexity / high costs Effective use of resources

Key issues adressed by the directive Directive 2011/24/EU of patients' rights in cross-border healthcare Right to choose and be reimbursed for healthcare provided by public or private providers located in the EU More transparency about their rights, treatment options or, the quality and safety levels of healthcare providers Strong focus on cooperation among Member States o Mutual recognition of prescription o ehealth o Health Technology Assessment o European Reference Networks Entry into force at National level 25 October 2013

National actions at the level of the Board of Member States: Ministeries of Health: National evaluation of expertise centres for rare diseases Recognition of expertise centres for rare endocrine diseases: national endorsement October 2014 - jan 2016 The trajectory towards an European Reference Network for Rare Endocrine Conditions

National actions at the level of the Board of Member States: Ministeries of Health: National evaluation of expertise centres for rare diseases Recognition of expertise centres for rare endocrine diseases: national endorsement Proces completed in march 2015 in the Netherlands, and late 2015 in Denmark Proces not even initiated in jan 2016 in many other member states October 2014 - jan 2016 The trajectory towards an European Reference Network for Rare Endocrine Conditions

National actions at the level of the Board of Member States: Ministeries of Health: National evaluation of expertise centres for rare diseases Recognition of expertise centres for rare endocrine diseases: national endorsement Lisbon 7-8 oct 2 nd ERN conference Olaf Hiort (ESPE) Proces completed in march 2015 in the Netherlands, and late 2015 in Denmark Proces not even initiated in jan 2016 in many other member states Jérôme Bertherat (ESE) Alberto Pereira October 2014 - jan 2016 The trajectory towards an European Reference Network for Rare Endocrine Conditions

1st ESPE-ESE statement National actions at the level of the Board of Member States: Ministeries of Health: National evaluation of expertise centres for rare diseases Recognition of expertise centres for rare endocrine diseases: national endorsement Lisbon 7-8 oct 2 nd ERN conference Olaf Hiort (ESPE) Proces completed in march 2015 in the Netherlands, and late 2015 in Denmark Proces not even initiated in jan 2016 in many other member states Jérôme Bertherat (ESE) Alberto Pereira October 2014 - jan 2016 The trajectory towards an European Reference Network for Rare Endocrine Conditions

1 march 2016 Lubeck 17 march 2016 Leiden The trajectory towards an European Reference Network for Rare Endocrine Conditions

EndoERN: broad thematic network ensuring all patients have a home excellency in diagnostics and treatment of hormonal disturbances throughout life Adrenal - Genetic Diabetes Growth DSD Genetic Endocrine Syndromes Pituitary - Thyroid birth senescence 9

The development of the European landscape for Rare Endocrine Conditions 10

Rare Endocrine Conditions ERN: Main Thematic grouping Information/communication E-health Outcome Research: database, registries, biobank, trials Longterm care Therapy Diagnosis Patient pituitary sex development and maturation adrenal disorders of calcium and phosphate homeostasis thyroid disorders of glucose and insulin homeostasis growth Education, training/ improved awareness Quality of care/ Value based health care genetic endocrine tumour syndromes

2nd ESPE-ESE statement (with main thematic groupings) ERN call Boston meeting: ESE-ESPE Decision on Endo-ERN coordination 16 march 16 2 april 2016 7 april 2016

The Network Application ECE 2016 Munich: Sunday 29 may 2016 Endo-ERN writing committee meeting

The Network (Application) 14 Insert > Header & footer 22-Dec-16

Governance Rare Endocrine Conditions ERN (Endo-ERN)

Mehul Dattani (London, UK) Nienke Biermasz (Leiden, NL) Svetlana Lajic (Karolinska, Sweden) Felix Beuschlein (München, Germany) Agnes Linglart (Paris, France) Lars Rejnmark (Aarhus, Denmark) Thomas Danne (Hannover, Germany) Chairs Olaf Hiort (Lubeck, Germany) Luca Persani (Milan, Italy) Irene Netchine (Paris, France) Gudmundur Johannsson (Gothenburg, Sweden) Michel Polak (Paris, France) Robin Peeters (Rotterdam, NL) Jo Blair (Liverpool, UK) Attila Patócs (Budapest, Hungary) Main Thematic groups Pituitary Sex Development and Maturation Adrenal Growth & Gen Obesity syndromes Disorders of calcium and phosphate homeostasis Thyroid Gen disorders of glucose and insulin homeostasis Genetic endocrine tumour syndromes Research & Science Martine Cools (Ghent, Belgium) Marta Korbonits (London, UK) Quality of care & Patient view Anna Nördenstrom (Karolinska, Sweden) Susan Webb (Barcelona, Spain) E-Health & ICT Faisal Ahmed (Glasgow, UK) Diagnostics & Laboratory analysis Anders Juul (Copenhagen, Denmark) George Mastorakos (Athens, Greece) Education & Teaching Violeta Iotova (Varna, Bulgaria) Jens Bollerslev (Oslo, Norway) Chairs Work Packages

The mission of Endo-ERN WP1 Education and Training WP5 Diagnostics and Laboratory analysis WP4 Quality of Care and Patient View WP2 ICT & E- Health WP3 Research and Science FPA co-funded: Management, coordination, communication, dissemination Attracting additional funding

Endo-ERN Work program structure WP1 Education and Training WP5 Diagnostics and Laboratory analysis WP4 Quality of Care and Patient View WP2 ICT & E- Health WP3 Research and Science 18 FPA co-funded: Management, coordination, communication, dissemination Attracting additional funding

[NAME OF ERN] Endo-ERN: Distribution of HCPs by country 1 1 1 71 Health Care Providers 19 countries 8 2 1 8 5 11 2 3 8 1 1 2 1 3 10 2

European network of Expertise Centers: how can it work optimally? ENDO-ERN 70 expertise centres Shorten delay in diagnosis: - Earlier referral - All required experts together - Best diagnostic techniques Best treatment Best education of all involved 20

European Network of expertise centers: patient travels to expertise? patient with rare endocrine condition patient with rare endocrine condition patient with rare endocrine condition patient with rare endocrine condition ENDO-ERN 70 expertise centres patient with rare endocrine condition patient with rare endocrine condition 21

European Network of expertise centers: expertise travels to the patient! patient with rare endocrine condition patient with rare endocrine condition patient with rare endocrine condition patient with rare `endocrine condition ENDO-ERN 70 expertise centres patient with rare endocrine condition patient with rare endocrine condition 22

Vision document Dutch Health Ministry: integral care, centered around the patient 23

National Networks that inter-connect with regional networks and ERNs National Network Regional Network HCP HCP HCP HCP HCP HCP HCP ENDO-ERN HCP HCP HCP HCP HCP HCP HCP 24

Update on Application 25 Insert > Header & footer 22-Dec-16

The call for ERNs Update on Application

Update on Application The call for ERNs 15/71 HCPs: full technical assessment (documentation review) 3/71 HCPs: on-site audit: - 24 oct 2016: Tartu (Estonia) (HCP) - 4 nov 2016: Leiden (NL) (Network + HCP) - 7 nov 2016: Luxembourg (L) (HCP) HCP audit: - patient-centered expert care (patient tracers) - patient empowerment - education - research

Update on Application The call for ERNs 15 november 2016: positive recommendation from IAB to the EC and BoMS for the Network and for 70/71 HCPs

Endo-ERN is ready to start! 15 dec 2016: Workshop on Registries (Glasgow, UK) 9-10 march 2017: 3 rd ERN Conference: Official installation of ERNs (Vilnius, Lithuania) 27 march 2017: Endo-ERN first General Assembly (Leiden, the NL) Initiation of operational ERN: - update all members, advisors, national coordinators, third parties - launch ENDO-ERN Logo & Website - approval of Governance structure & Board Terms of Reference - each member (HCP) signs Members Role & Responsibilities 29 Insert > Header & footer 22-Dec-16